Bayer Aktiengesellschaft Share Price Other OTC
Equities
BAYRY
US0727303028
Pharmaceuticals
Sales 2024 * | 47.09B 50.47B 4,031B | Sales 2025 * | 47.95B 51.39B 4,104B | Capitalization | 26.87B 28.8B 2,300B |
---|---|---|---|---|---|
Net income 2024 * | 2.08B 2.23B 178B | Net income 2025 * | 3.17B 3.39B 271B | EV / Sales 2024 * | 1.27 x |
Net Debt 2024 * | 33.1B 35.48B 2,834B | Net Debt 2025 * | 29.67B 31.8B 2,540B | EV / Sales 2025 * | 1.18 x |
P/E ratio 2024 * |
12.5
x | P/E ratio 2025 * |
8.41
x | Employees | - |
Yield 2024 * |
0.4% | Yield 2025 * |
0.85% | Free-Float | 99.97% |
Latest transcript on Bayer Aktiengesellschaft
Managers | Title | Age | Since |
---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 31/03/23 |
Director of Finance/CFO | 55 | 25/04/18 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 31/03/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 31/03/17 |
Director/Board Member | 68 | 31/03/17 | |
Alberto Weisser
BRD | Director/Board Member | 67 | 31/03/21 |
1st Jan change | Capi. | |
---|---|---|
+33.25% | 699B | |
+28.59% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.81% | 236B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 149B |